Early Screening and Monitoring Can Reduce Type 1 Diabetes Severity at Diagnosis

A new study compared how Type 1 diabetes presented in two groups of children: 126 who were identified through the Type 1 Diabetes Prediction and Prevention (DIPP) screening program and 440 children diagnosed outside of screening. The DIPP participants were identified based on genetic risk factors and then followed closely over time.

At the moment of diagnosis, the difference between the groups was striking. Only 5.6% of DIPP children developed diabetic ketoacidosis (a serious complication where blood becomes too acidic), compared to 23.6% of children diagnosed without screening. DIPP children also had fewer cases of dehydration, electrolyte imbalances, and needed intensive care far less often. Their hospital stays were shorter overall.

Blood sugar control also differed significantly. At diagnosis, DIPP children had median HbA1c levels of 46 mmol/mol (6.4%), while non-screened children measured 99 mmol/mol (11.2%). This reflects how much better controlled the DIPP group's blood sugar had been leading up to diagnosis.

The advantages of early identification didn't stop at diagnosis. One year after diagnosis, DIPP children continued to show better outcomes. Their HbA1c levels were 55 mmol/mol (7.2%) compared to 61 mmol/mol (7.7%) in the non-screened group, indicating more stable blood sugar management.

Insulin requirements also remained lower in the DIPP group. At diagnosis, screened children needed 0.11 units of insulin per kilogram of body weight daily, versus 0.74 units/kg/day for non-screened children. By one year, DIPP children used 0.57 units/kg/day compared to 0.70 units/kg/day in the other group.

Type 1 diabetes develops gradually. In the months or years before diagnosis, the immune system slowly attacks insulin-producing cells in the pancreas. The DIPP study suggests that identifying children at genetic risk and monitoring them closely may help doctors diagnose Type 1 diabetes earlier in this process—before severe symptoms develop.

Diagnosing Type 1 diabetes at an earlier stage appears to mean the pancreas still has more insulin-producing capacity remaining, which may explain the lower insulin needs and better blood sugar control seen in the screened group. Avoiding severe complications like ketoacidosis at diagnosis also means less strain on the body and potentially shorter, less intensive medical treatment during those critical early weeks.

This research supports the growing interest in population-based screening for Type 1 diabetes risk. While screening programs are still not widely available in all countries or healthcare systems, this evidence shows they can have measurable benefits for children who participate.

If you have a family member with Type 1 diabetes or are interested in learning whether genetic screening is available in your area, talk with your healthcare provider. Screening identifies risk, not disease—and knowing your risk allows for the kind of close monitoring that this study shows can make a real difference in how Type 1 diabetes appears and is managed when diagnosis does occur.

Source: Diabetes care. Evidence type: PubMed indexed literature. Type1Cure is an information and intelligence hub, not a medical advice service. This article summarizes published research and does not provide diagnosis, treatment, or personal medical guidance. Always talk to your own care team before changing anything about your Type 1 diabetes management.